Skip to main content
  • 369 Accesses

Zusammenfassung

Eine chronische HPV-Infektion mit Hochrisikosubtypen ist der wichtigste Risikofaktor für die Entstehung des Zervixkarzinoms.

Das Zervixkarzinom ist ein ideales Modell zur Früherkennung mittels Zytologiescreening.

Die radikale Hysterektomie oder die Radiotherapie des Beckens stellen den Therapiestandard im Frühstadium dar (Ib1-IIa).

Die Kombination einer Strahlentherapie mit Chemotherapie stellt die Standardbehandlung bei den fortgeschrittenen Stadien IIb-IV dar.

Rezidive treten bevorzugt im Becken auf.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Benedet J, Anderson G (1996) Stage IA carcinoma of the cervix revisited. Obstet Gynecol 87: 1052–1059

    Article  PubMed  CAS  Google Scholar 

  • Benedetti-Panici P, Greggi S, Colombo A et al. (2001) Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 20: 179–188

    Article  Google Scholar 

  • Burghardt E (1984) Kolposkopie, spezielle Zervixpathologie. Thieme, Stuttgart New York

    Google Scholar 

  • Burghardt E, Baltzer J, Tulusan H, Haas J (1992) Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 70: 648–655

    PubMed  CAS  Google Scholar 

  • Eifel P, Winter K, Morris M et al. (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90—01. J Clin Oncol 22: 872–880

    Article  PubMed  Google Scholar 

  • Friedberg V, Herzog R (1988) Die Therapie des Zervixkarzinoms. In: Friedberg V, Thomsen K (Hrsg) Gynäkologie und Geburtshilfe. Spezielle Gynäkologie 2. Thieme, Stuttgart New York, S 134–161

    Google Scholar 

  • Fyles AW, Milosevic M, Pintilie M et al. (2000) Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 57: 13–19

    Article  PubMed  CAS  Google Scholar 

  • Girardi F, Pickel H, Winter R (1993) Pelvic and parametrial lymph nodes in the quality control of the surgical treatment of cervical cancer. Gynecol Oncol 50: 330–333

    Article  PubMed  CAS  Google Scholar 

  • Hacker N, Wain G, Nicklin J (1995) Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 5: 250–256

    Article  PubMed  Google Scholar 

  • Kapp KS, Stuecklschweiger GF, Kapp DS et al. (1997) Carcinoma of the cervix; analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy. Radiother Oncol 42: 143–153

    Article  PubMed  CAS  Google Scholar 

  • Kapp KS, Poschauko J, Geyer E et al. (2002) Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 54: 58–66

    Article  PubMed  Google Scholar 

  • Kaufmann M, Costa SD, Scharl A (Hrsg) (2003) Die Gynäkologie. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Koutsky L, Ault K, Wheeler C et al. (2002) Controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347: 1645–1651

    Article  PubMed  CAS  Google Scholar 

  • Landoni F, Maneo A, Colombo A et al. (1997) Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350: 535–540

    Article  PubMed  CAS  Google Scholar 

  • Peters WA, Liu P, Barrett R et al. (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18: 1606–1613

    PubMed  CAS  Google Scholar 

  • Petru E, Tamussino K, Lahousen M et al. (1989) Pelvic and paraaortic lymphocysts after radical surgery because of cervical and ovarian cancer. Am J Obstet Gynecol 161: 937–941

    PubMed  CAS  Google Scholar 

  • Petru E, Pasterk C, Reich O et al. (2005) Small cell carcinoma of the uterus and vagina. Experience with ten patients. Arch Gynecol Obstet 271: 316–319

    Article  PubMed  Google Scholar 

  • Podczaski E, Palombo C, Manetta A et al. (1989) Assessment of pre-treatment laparotomy in patients with cervical carcinoma prior to radiotherapy. Gynecol Oncol 33: 71–75

    Article  PubMed  CAS  Google Scholar 

  • Reich O, Lahousen M, Pickel H et al. (2002) Cervical intraepithelial neoplasia III: long-term follow-up after cold-knife coization with involved margins. Obstet Gynecol 99: 193–196

    Article  PubMed  Google Scholar 

  • Rose P, Bundy B, Watkins E et al. (1999) Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340: 1144–1153

    Article  PubMed  CAS  Google Scholar 

  • Sardi J, Sananes C, Giaroli A et al. (1993) Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol 49: 156–165

    Article  PubMed  CAS  Google Scholar 

  • Sawaya G, McConnell J, Kulasingam S et al. (2003) Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 349: 1501–1509

    Article  PubMed  CAS  Google Scholar 

  • Shingleton H, Soong S, Gelder M et al. (1989) Clinical and histopathological factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 73: 1027–1034

    Article  PubMed  CAS  Google Scholar 

  • Stehman FB, Bundy BN, DiSaia PJ et al. (1991) Carcinoma of the cervix treated with radiation therapy I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67: 2776–2785

    PubMed  CAS  Google Scholar 

  • Sutton G, Bundy B, Delgado G et al. (1992) Ovarian metastases in stage Ib carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Obstet Gynecol 166: 50–53

    PubMed  CAS  Google Scholar 

  • Vange V, Weverling G, Ketting B et al. (1995) The prognosis of cervical cancer associated with pregnancy: a matched chort study. Obstet Gynecol 85: 1022–1026

    Article  PubMed  Google Scholar 

  • Webb M, Symmonds R (1980) Site of recurrence of cervical cancer after radical hysterectomy. Am J Obstet Gynecol 138: 813–817

    PubMed  CAS  Google Scholar 

  • Winter R, Petru E, Haas J (1988) Pelvic and para-aortic lymphadenectomy in cervical cancer. Baillieres Clin Obstet Gynaecol 2: 857–866

    PubMed  CAS  Google Scholar 

  • Winter R, Lahousen M, Haas J (1998) Long-term results in cervical cancer patients with positive p araaortic nodes. Gynecol Oncol 68: S107

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Petru, E., Kapp, K., Reich, O., Winter, R. (2005). Maligne Tumoren der Cervix uteri. In: Praxisbuch Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30015-5_4

Download citation

  • DOI: https://doi.org/10.1007/3-540-30015-5_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25667-0

  • Online ISBN: 978-3-540-30015-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics